Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Bull World Health Organ ; 102(4): 255-264, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38562195

ABSTRACT

Objective: To assess the impact of an open fracture intervention bundle on clinical management and patient outcomes of adults in Malawi with open tibia fractures. Methods: We conducted a before-and-after implementation study in Malawi in 2021 and 2022 to assess the impact of an open fracture intervention bundle, including a national education course for clinical officers and management guidelines for open fractures. We recruited 287 patients with open tibia fractures. The primary outcome was a before-and-after comparison of the self-reported short musculoskeletal function assessment score, a measure of patient function. Secondary outcomes included clinical management; and clinician knowledge and implementation evaluation outcomes of 57 health-care providers attending the course. We also constructed multilevel regression models to investigate associations between clinical knowledge, patient function, and implementation evaluation before and after the intervention. Findings: The median patient function score at 1 year was 6.8 (interquartile range, IQR: 1.5 to 14.5) before intervention and 8.4 (IQR: 3.8 to 23.2) after intervention. Compared with baseline scores, we found clinicians' open fracture knowledge scores improved 1 year after the intervention was implemented (mean posterior difference: 1.6, 95% highest density interval: 0.9 to 2.4). However, we found no difference in most aspects of clinicians' open fracture management practice. Conclusion: Despite possible improvement in clinician knowledge and positive evaluation of the intervention implementation, our study showed that there was no overall improvement in clinical management, and weak evidence of worsening patient function 1 year after injury, after implementation of the open fracture intervention bundle.


Subject(s)
Fractures, Open , Tibial Fractures , Adult , Humans , Fractures, Open/surgery , Fractures, Open/complications , Malawi , Tibia , Tibial Fractures/surgery , Tibial Fractures/complications , Treatment Outcome
4.
Dermatopathology (Basel) ; 9(4): 368-378, 2022 Nov 27.
Article in English | MEDLINE | ID: mdl-36547217

ABSTRACT

The year 2022 will herald approximately 100,000 new cases of cutaneous melanoma (CM), and over 7000 deaths from CM. Over the past 40 years, CM incidence has increased nearly six-fold; however, annual mortality has remained relatively constant. These trends encapsulate the phenomenon of overdiagnosis. Increased recognition of indolent lesions that appear histologically malignant may be leading to a melanoma epidemic. Enhanced melanoma awareness, screening efforts, physician uncertainty, medical-legal pressures, and diagnostic scrutiny using tools like immunohistochemical staining, mole mapping, dermoscopy, confocal microscopy, and molecular diagnostics contribute to increased CM diagnosis. As a result, current melanoma staging and treatment guidelines are being challenged. Existing standards fail to accurately identify histologically benign lesions that are lethal or, conversely, histologically malignant lesions that are innocuous. Healthcare systems and, more importantly, patients suffer from this diagnostic ambiguity that leads to the over-treatment of innocuous melanomas and under-treatment of aggressive melanomas. As dermatology continues to experience a shift towards earlier diagnosis of melanoma, management strategies must adapt. Herein, we review factors that may contribute to the increased incidence of melanoma, emphasize deficiencies in current staging systems, and provide insights into the future of melanoma management via precision medicine.

5.
Preprint in English | medRxiv | ID: ppmedrxiv-22275432

ABSTRACT

Wastewater-based epidemiology (WBE) monitoring can play a key role in managing future pandemics because it covers both pre-symptomatic and asymptomatic cases, especially in densely populated areas with limited community health care. In the present work, wastewater monitoring was employed in Ahmedabad, India, after the successful containment of the first wave of COVID-19 to predict resurgence of the disease in the expected second wave of the pandemic. Here we show wastewater levels of COVID-19 virus particles (i.e., SARS-CoV-2) positively correlated with the number of confirmed clinical cases during the first wave, and provided early detection of COVID-19 presence before the second wave in Ahmedabad and an WBE-based city zonation plan was developed for health protection. A eight-month data of Surveillance of Wastewater for Early Epidemic Prediction (SWEEP) was gathered, including weekly SARS-CoV-2 RNA wastewater analysis (n=287) from nine locations between September 2020 and April 2021. Across this period, 258 out of 287 samples were positive for least two out of three SARS-CoV-2 genes (N, ORF 1ab, and S). Monitoring showed a substantial decline in all three gene markers between October and September 2020, followed by an abrupt increase in November 2020. Similar changes were seen in March 2021, which preceded the second COVID-19 wave. Measured wastewater ORF-1ab gene copies ranged from 6.1 x 102 (October, 2020) to 1.4 x 104 (November, 2020) copies/mL, and wastewater gene levels typically lead confirmed cases by one to two weeks. The study highlights the value of WBE as a monitoring tool to predict waves within a pandemic, identifying local disease hotspots within a city and guiding rapid management interventions. HighlightsO_LIEight-months of SARS-CoV-2 gene variations explicitly predicts 2nd COVID-19 wave. C_LIO_LI258 out of 287 wastewater samples were positive for SARS-CoV-2 genes. C_LIO_LIWBE offers a lead time of 1-2 weeks relative to clinical cases. C_LIO_LIModel suggests that ORF 1ab gene is the most effective as a marker gene in WBE study. C_LIO_LIWBE RT-PCR screening for pathogens should be mandatory for global health monitoring. C_LI

6.
Front Psychol ; 11: 1566, 2020.
Article in English | MEDLINE | ID: mdl-32760325

ABSTRACT

In recent decades, there has been increasing interest in (re)connecting people with nature to foster sustainability outcomes. There is a growing body of evidence suggesting a relationship between connection with nature and pro-environmental behaviors. Connection with nature has often been conceptualized as a unidimensional construct, and although recent evidence suggests that it is multidimensional, there is ongoing debate regarding the dimensions that make up connection with nature. Existing multidimensional connection with nature instruments capture similar dimensions, yet they are lengthy and may not have practical application in real-world contexts. This research sought to clarify the dimensions of connection with nature and to develop and validate an abbreviated yet multidimensional connection with nature instrument-the CN-12. Analyses of two large datasets revealed three dimensions of connection with nature-identity, experience, and philosophy. Results suggested that the CN-12 and its three dimensions are positively correlated with: (1) environmental and altruistic values; (2) time spent in nature; and (3) a range of pro-environmental behaviors. Results also suggested that the CN-12 and its three dimensions are stable over time and are positively correlated with two existing multidimensional connection with nature instruments, the Nature Relatedness (NR) Scale and Environmental Identity (EID) Scale. The utility of the CN-12 for exploring human connections with nature and the role of fostering connection with nature to increase engagement in pro-environmental behaviors are discussed.

7.
BMJ Paediatr Open ; 1(1): e000084, 2017.
Article in English | MEDLINE | ID: mdl-29637122

ABSTRACT

INTRODUCTION: Perthes disease (PD) is an idiopathic disorder presenting with avascular necrosis to the femoral head, which frequently results in flattening. Long-term function is directly related to the subsequent femoral head sphericity. Current treatment includes mechanical modalities and surgical procedures, which are therapeutic but are not uniformly able to prevent collapse. The use of the nitrogen-containing bisphosphonate zoledronic acid (ZA) to inhibit osteoclastic bone resorption is aimed at preserving femoral head strength, reducing collapse and thus maintaining shape. The proposed multicentre, prospective, randomised controlled trial intends to evaluate the efficacy of ZA treatment in PD. METHODS AND ANALYSIS: An open-label randomised control trial recruiting 100 children (50 each treatment arm) 5 to 16 years old with unilateral PD. Subjects are randomly assigned to either (a) ZA and standard care or (b) Standard care. The primary outcome measure is deformity index (DI), a radiographic parameter of femoral head roundness assessed at 24 months, following 12 months of ZA treatment (3-monthly doses of ZA 0.025 mg/kg at baseline, 3, 6, 9 and 12 months) plus 12 months observation (group A) or 24 months of observation (group B). Secondary outcome measures are femoral head subluxation, Faces Pain scale, Harris hip score and quality of life. Assessments are made at baseline, 3 monthly during the first year of follow-up and then 6 monthly, until the 24th month. ETHICS AND DISSEMINATION: The study commenced following the written approval from the Human Research Ethics Committee. Safety considerations regarding the effects of ZA are monitored which include the subject's symptomatology, mineral status, bone mass and turnover activity, and metaphyseal modelling. Data handling plan requires that all documents, clinical information, biological samples and investigation results will be held in strict confidence by study investigators to preserve its safety and confidentiality. TRIAL REGISTRATION NUMBER: Australian and New Zealand Clinical Trials ACTRN12610000407099, pre-results.

8.
Article in English | WPRIM (Western Pacific) | ID: wpr-759154

ABSTRACT

PURPOSE: A pneumatic tourniquet is commonly used in total knee arthroplasty (TKA) to improve surgical field visualisation but may result in quadriceps muscle ischaemia. We performed this study to analyse the effect of the tourniquet on recovery following TKA. MATERIALS AND METHODS: A prospective randomised single-blinded trial was undertaken to examine the effect of the tourniquet on post-operative pain, swelling, blood loss, quadriceps function and outcome following TKA. Twenty patients with osteoarthritis of the knee were randomised to tourniquet or no tourniquet groups. Quadriceps function was assessed using surface electromyography (EMG) during active knee extension. RESULTS: The no tourniquet group had significantly less pain in the early post-operative period compared to the tourniquet group. There was no difference in Oxford knee score, range of motion, or thigh and knee swelling up to 12 months post-operatively. Quadriceps function, measured by surface EMG, was compromised for the first six months post-surgery by tourniquet use. The radiological cement mantle at the bone prosthesis interface at 12-month follow-up was not affected by the absence of a tourniquet. CONCLUSIONS: We believe that it is safe and beneficial for our patients to routinely perform TKA without a tourniquet.


Subject(s)
Humans , Arthroplasty , Electromyography , Follow-Up Studies , Knee , Osteoarthritis , Prospective Studies , Prostheses and Implants , Quadriceps Muscle , Range of Motion, Articular , Thigh , Tourniquets
9.
JOP ; 14(5): 510-4, 2013 Sep 10.
Article in English | MEDLINE | ID: mdl-24018597

ABSTRACT

CONTEXT: Glucagonomas of the pancreas are neuroendocrine tumours (NETs) that arise from well-differentiated neuroendocrine cells within the pancreatic islets. They are considered to be aggressive NETs and often have metastases at initial presentation. In contrast localised glucagonoma without metastatic spread may have prolonged disease free survival with radical resectional surgery. CASE REPORT: The authors present a case of a glucagonoma that initially presented with classical necrolytic migratory erythema and a large solitary mass in the body and tail of the pancreas that was surgically resected. Five years after surgery the patient presented with increased serum glucagon levels and a mass in the right ovary. Pathology of the resected ovary after oophorectomy identified this as an isolated metastatic glucagonoma. CONCLUSION: Glucagonoma is a rare pancreatic NET that has significant malignant potential. This is the first case of a pancreatic glucagonoma metastasising to the ovary 5 years after radical distal pancreatosplenectomy.


Subject(s)
Glucagonoma/pathology , Ovarian Neoplasms/secondary , Ovary/pathology , Pancreatic Neoplasms/pathology , Female , Glucagonoma/diagnosis , Glucagonoma/surgery , Humans , Middle Aged , Neuroendocrine Tumors/diagnosis , Neuroendocrine Tumors/pathology , Neuroendocrine Tumors/surgery , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/surgery , Ovary/surgery , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/surgery , Time Factors
10.
PLoS One ; 7(5): e34183, 2012.
Article in English | MEDLINE | ID: mdl-22606224

ABSTRACT

Bovine neonatal pancytopenia (BNP; previously known as idiopathic haemorrhagic diathesis and commonly known as bleeding calf syndrome) is a novel haemorrhagic disease of young calves which has emerged in a number of European countries during recent years. Data were retrospectively collected during June to November 2010 for 56 case calves diagnosed with BNP between 17 March and 7 June of the same year. These were compared with 58 control calves randomly recruited from herds with no history of BNP. Multivariable logistic regression analysis showed that increased odds of a calf being a BNP case were associated with its dam having received PregSure® BVD (Pfizer Animal Health) vaccination prior to the birth of the calf (odds ratio (OR) 40.78, p<0.001) and its herd of origin being located in Scotland (OR 9.71, p = 0.006). Decreased odds of a calf being a BNP case were associated with the calf having been kept outside (OR 0.11, p = 0.006). The longer that a cattle herd had been established on the farm was also associated with decreased odds of a calf in that herd being a BNP case (OR 0.97, p = 0.011).


Subject(s)
Cattle Diseases/etiology , Pancytopenia/veterinary , Animals , Animals, Newborn , Case-Control Studies , Cattle , Diarrhea Viruses, Bovine Viral/immunology , Female , Logistic Models , Male , Pancytopenia/etiology , Pregnancy , Retrospective Studies , Risk Factors , United Kingdom , Vaccination/adverse effects , Vaccination/veterinary , Viral Vaccines/administration & dosage , Viral Vaccines/adverse effects
11.
Blood ; 119(19): 4467-75, 2012 May 10.
Article in English | MEDLINE | ID: mdl-22415752

ABSTRACT

Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However, several issues need revisiting, including the criteria for identification of BCR stereotypy and its actual frequency as well as the identification of "CLL-biased" features in BCR Ig stereotypes. To this end, we examined 7596 Ig VH (IGHV-IGHD-IGHJ) sequences from 7424 CLL patients, 3 times the size of the largest published series, with an updated version of our purpose-built clustering algorithm. We document that CLL may be subdivided into 2 distinct categories: one with stereotyped and the other with nonstereotyped BCRs, at an approximate ratio of 1:2, and provide evidence suggesting a different ontogeny for these 2 categories. We also show that subset-defining sequence patterns in CLL differ from those underlying BCR stereotypy in other B-cell malignancies. Notably, 19 major subsets contained from 20 to 213 sequences each, collectively accounting for 943 sequences or one-eighth of the cohort. Hence, this compartmentalized examination of VH sequences may pave the way toward a molecular classification of CLL with implications for targeted therapeutic interventions, applicable to a significant number of patients assigned to the same subset.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell/classification , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Molecular Diagnostic Techniques/methods , Molecular Targeted Therapy , Receptors, Antigen, B-Cell/genetics , Amino Acid Sequence , Gene Rearrangement, B-Lymphocyte/genetics , Humans , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Variable Region/genetics , Immunophenotyping , Leukemia, Lymphocytic, Chronic, B-Cell/metabolism , Models, Biological , Molecular Sequence Data , Molecular Targeted Therapy/methods , Molecular Targeted Therapy/trends , Receptors, Antigen, B-Cell/metabolism , Somatic Hypermutation, Immunoglobulin/genetics
12.
J Pediatr Orthop ; 31(4): 458-64, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21572286

ABSTRACT

BACKGROUND: The new Fassier-Duval Telescopic IM System (FD-rod) has the advantage of a single entry point over the traditional telescopic rods such as the Bailey-Dubow or Sheffield rods. Although encouraging early results were presented by the originators of the technique at international meetings, there is no formal publication in the literature as yet. METHODS: We performed a chart and x-ray review of the first 24 consecutive FD-rod insertions in 15 patients (age, 1.5 to 12.5 y) with a minimum of 1-year follow up (1 to 2.4 y) after implantation of femoral and/or tibial FD-rods. Diagnoses included with osteogenesis imperfecta (OI) (15 cases, 9 patients), and other conditions such as congenital tibial pseudarthrosis (CPT) in neurofibromatosis type 1 (NF1) (2 cases), and epidermal naevus syndrome (1 case). In patients with hypophosphataemic rickets (6 cases, 2 patients) the FD-rods were combined with an Ilizarov frame. RESULTS: We found the OI patient group associated with a 13% reoperation rate (2 of 15 cases) for proximal rod migration and a 40% complication rate (6 of 15 cases): rod migration and limited telescoping (5) and intraoperative joint intrusion (1). There were no infections. All the NF1 CPT (2) and epidermal naevus syndrome (1) cases required several reoperations for nonunion, loss of fixation, shortening (negative telescoping), migration, and/or joint intrusion-mainly due to the severe underlying pathology with insufficient longitudinal or torsional stability and diminished healing capacity. In hypophosphataemic rickets (combined with Ilizarov frame fixation) we found a 50% complication rate (3 of 6 cases) and a 17% reoperation rate (1 of 6): 2 FD-rods did not telescope and 1 case of peroneal neuropraxia required neurolysis. CONCLUSIONS: In our experience the technique of using FD rods is demanding and associated with some intraoperative and postoperative pitfalls. We are happy to continue its use in OI patients when there is longitudinal stability and sufficient bone healing. However, in circumstances of insufficient stability and bone healing potential, further stabilization that can be achieved with an Ilizarov frame may be beneficial.


Subject(s)
Bone Diseases/surgery , Familial Hypophosphatemic Rickets/surgery , Orthopedic Fixation Devices , Osteogenesis Imperfecta/surgery , Bone Diseases/diagnostic imaging , Bone Diseases/pathology , Child , Child, Preschool , Equipment Failure , Familial Hypophosphatemic Rickets/diagnostic imaging , Familial Hypophosphatemic Rickets/pathology , Female , Follow-Up Studies , Fracture Fixation, Intramedullary/instrumentation , Fracture Fixation, Intramedullary/methods , Humans , Ilizarov Technique , Infant , Male , Osteogenesis Imperfecta/diagnostic imaging , Osteogenesis Imperfecta/pathology , Postoperative Complications , Radiography , Reoperation , Retrospective Studies , Treatment Outcome
13.
Cytotherapy ; 11(5): 516-26, 2009.
Article in English | MEDLINE | ID: mdl-19562576

ABSTRACT

BACKGROUND AIMS: Cell-based gene therapy is an alternative to viral and non-viral gene therapy. Emerging evidence suggests that mesenchymal stem cells (MSC) are able to migrate to sites of tissue injury and have immunosuppressive properties that may be useful in targeted gene therapy for sustained specific tissue engraftment. METHODS: In this study, we injected intravenously (i.v.) 1x10(6) MSC, isolated from green fluorescent protein (GFP) transgenic rats, into Rif-1 fibrosarcoma-bearing C3H/HeN mice. The MSC had been infected using a lentiviral vector to express stably the luciferase reporter gene (MSC-GFP-luci). An in vivo imaging system (IVIS 200) and Western blotting techniques were used to detect the distribution of MSC-GFP-luci in tumor-bearing animals. RESULTS: We observed that xenogenic MSC selectively migrated to the tumor site, proliferated and expressed the exogenous gene in subcutaneous fibrosarcoma transplants. No MSC distribution was detected in other organs, such as the liver, spleen, colon and kidney. We further showed that the FGF2/FGFR pathways may play a role in the directional movement of MSC to the Rif-1 fibrosarcoma. We performed in vitro co-culture and in vivo tumor growth analysis, showing that MSC did not affect the proliferation of Rif-1 cells and fibrosarcoma growth compared with an untreated control group. Finally, we demonstrated that the xenogenic MSC stably expressing inducible nitric oxide synthase (iNOS) protein transferred by a lentivirus-based system had a significant inhibitory effect on the growth of Rif-1 tumors compared with MSC alone and the non-treatment control group. CONCLUSIONS: iNOS delivered by genetically modified iNOS-MSC showed a significant anti-tumor effect both in vitro and in vivo. MSC may be used as a target gene delivery vehicle for the treatment of fibrosarcoma and other tumors.


Subject(s)
Fibrosarcoma/genetics , Fibrosarcoma/therapy , Genetic Therapy , Mesenchymal Stem Cells/cytology , Animals , Cell Line , Cell Movement/drug effects , Cell Proliferation/drug effects , Fibroblast Growth Factor 2/pharmacology , Green Fluorescent Proteins/metabolism , Humans , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/enzymology , Mice , Neoplasm Transplantation , Nitric Oxide Synthase Type II/metabolism , Rats , Subcutaneous Tissue/drug effects , Subcutaneous Tissue/pathology , Transplantation, Heterologous
16.
Psychiatr Serv ; 57(12): 1792-4, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17158496

ABSTRACT

OBJECTIVE: The evidence base for using cognitive-behavioral therapy in schizophrenia is well established; it is recommended in guidelines by the Schizophrenia Patient Outcomes Research Team. METHODS: Data were examined regarding referral patterns for patients with schizophrenia who were seen by one of four psychiatrists at the mental health center providing services to West Southampton (England). RESULTS: Of the 142 patients identified, 69 had and 73 had not been referred for cognitive-behavioral therapy. Patients tended not to be referred if they were considered to be doing well and not in need of therapy or were unlikely to engage. CONCLUSIONS: In a location where cognitive-behavioral therapy for schizophrenia was readily available, half of all patients were considered appropriate for referral. Improved engagement skills and more assertive outreach by therapists and consideration by referrers of the benefits of relapse prevention might bring the benefits of cognitive-behavioral therapy to a still broader group.


Subject(s)
Cognitive Behavioral Therapy/statistics & numerical data , Community Mental Health Centers/standards , Health Services Accessibility , Psychiatry/standards , Referral and Consultation/statistics & numerical data , Schizophrenia/therapy , Adolescent , Adult , England , Female , Humans , Interviews as Topic , Male , Middle Aged , Psychiatry/methods , Retrospective Studies
17.
J Biol Chem ; 281(46): 35008-20, 2006 Nov 17.
Article in English | MEDLINE | ID: mdl-16963453

ABSTRACT

We found that engagement of beta2 integrins on human neutrophils increased the levels of GTP-bound Rap1 and Rap2. Also, the activation of Rap1 was blocked by PP1, SU6656, LY294002, GF109203X, or BAPTA-AM, which indicates that the downstream signaling events in Rap1 activation involve Src tyrosine kinases, phosphoinositide 3-kinase, protein kinase C, and release of calcium. Surprisingly, the beta2 integrin-induced activation of Rap2 was not regulated by any of the signaling pathways mentioned above. However, we identified nitric oxide as the signaling molecule involved in beta2 integrin-induced activation of Rap1 and Rap2. This was illustrated by the fact that engagement of beta2 integrins increased the production of nitrite, a stable end-product of nitric oxide. Furthermore, pretreatment of neutrophils with Nomega-monomethyl-L-arginine, or 1400W, which are inhibitors of inducible nitric-oxide synthase, blocked beta2 integrin-induced activation of Rap1 and Rap2. Similarly, Rp-8pCPT-cGMPS, an inhibitor of cGMP-dependent serine/threonine kinases, also blunted the beta2 integrin-induced activation of Rap GTPases. Also nitric oxide production and its downstream activation of cGMP-dependent serine/threonine kinases were essential for proper neutrophil adhesion by beta2 integrins. Thus, we made the novel findings that beta2 integrin engagement on human neutrophils triggers production of nitric oxide and its downstream signaling is essential for activation of Rap GTPases and neutrophil adhesion.


Subject(s)
CD18 Antigens/metabolism , Cell Adhesion/physiology , Neutrophils/metabolism , Nitric Oxide/metabolism , rap GTP-Binding Proteins/metabolism , rap1 GTP-Binding Proteins/metabolism , Calcium Signaling , Gene Expression Regulation, Enzymologic , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Manganese/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Protein Kinase C/metabolism , rap1 GTP-Binding Proteins/antagonists & inhibitors , src-Family Kinases/metabolism
18.
Rev. paul. odontol ; 27(4): 37-39, out.-dez. 2005. ilus
Article in Portuguese | LILACS, BBO - Dentistry | ID: lil-437448

ABSTRACT

O presente trabalho aborda as características clínicas e histopatológicas das cicatrizes hipertróficas e quelóides, além do tratamento proposto atualmente na literatura. É relatado ainda, um caso clínico de cicatriz hipertrófica em mucosa interna de lábio superior, onde se utilizou, intralesionalmente, o acetato de triamcinolona como terapia


Subject(s)
Humans , Male , Cicatrix, Hypertrophic/drug therapy , Keloid/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL